328 related articles for article (PubMed ID: 30154232)
1. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
2. AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
Coant N; García-Barros M; Zhang Q; Obeid LM; Hannun YA
Oncogene; 2018 Jul; 37(28):3852-3863. PubMed ID: 29662189
[TBL] [Abstract][Full Text] [Related]
3. Role of neutral ceramidase in colon cancer.
García-Barros M; Coant N; Kawamori T; Wada M; Snider AJ; Truman JP; Wu BX; Furuya H; Clarke CJ; Bialkowska AB; Ghaleb A; Yang VW; Obeid LM; Hannun YA
FASEB J; 2016 Dec; 30(12):4159-4171. PubMed ID: 27609772
[TBL] [Abstract][Full Text] [Related]
4. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
5. Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.
Coant N; Hannun YA
Adv Biol Regul; 2019 Jan; 71():141-146. PubMed ID: 30389354
[TBL] [Abstract][Full Text] [Related]
6. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
7. Measurement of neutral ceramidase activity in vitro and in vivo.
Simoes M; Saleh A; Choi YM; Airola MV; Haley JD; Coant N
Anal Biochem; 2022 Apr; 643():114577. PubMed ID: 35134389
[TBL] [Abstract][Full Text] [Related]
8. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
[TBL] [Abstract][Full Text] [Related]
9. Neutral ceramidase-active site inhibitor chemotypes and binding modes.
Coant N; Bickel JD; Rahaim R; Otsuka Y; Choi YM; Xu R; Simoes M; Cariello C; Mao C; Saied EM; Arenz C; Spicer TP; Bannister TD; Tonge PJ; Airola MV; Scampavia L; Hannun YA; Rizzo RC; Haley JD
Bioorg Chem; 2023 Oct; 139():106747. PubMed ID: 37531819
[TBL] [Abstract][Full Text] [Related]
10. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.
Tani M; Igarashi Y; Ito M
J Biol Chem; 2005 Nov; 280(44):36592-600. PubMed ID: 16126722
[TBL] [Abstract][Full Text] [Related]
11. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.
Snider AJ; Wu BX; Jenkins RW; Sticca JA; Kawamori T; Hannun YA; Obeid LM
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):124-30. PubMed ID: 22940715
[TBL] [Abstract][Full Text] [Related]
12. Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.
Novgorodov SA; Wu BX; Gudz TI; Bielawski J; Ovchinnikova TV; Hannun YA; Obeid LM
J Biol Chem; 2011 Jul; 286(28):25352-62. PubMed ID: 21613224
[TBL] [Abstract][Full Text] [Related]
13. Neutral Ceramidase Secreted Via Exosome Protects Against Palmitate-Induced Apoptosis in INS-1 Cells.
Tang S; Luo F; Feng YM; Wei X; Miao H; Lu YB; Tang Y; Ding DF; Jin JF; Zhu Q
Exp Clin Endocrinol Diabetes; 2017 Feb; 125(2):130-135. PubMed ID: 28008587
[No Abstract] [Full Text] [Related]
14. Neutral ceramidase activity inhibition is involved in palmitate-induced apoptosis in INS-1 cells.
Luo F; Feng Y; Ma H; Liu C; Chen G; Wei X; Mao X; Li X; Xu Y; Tang S; Wen H; Jin J; Zhu Q
Endocr J; 2017 Aug; 64(8):767-776. PubMed ID: 28674283
[TBL] [Abstract][Full Text] [Related]
15. Low-grade elevation of palmitate and lipopolysaccharide synergistically induced β-cell damage via inhibition of neutral ceramidase.
Xu YN; Wang Z; Zhang SK; Xu JR; Pan ZX; Wei X; Wen HH; Luo YS; Guo MJ; Zhu Q
Mol Cell Endocrinol; 2022 Jan; 539():111473. PubMed ID: 34610358
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase.
Airola MV; Allen WJ; Pulkoski-Gross MJ; Obeid LM; Rizzo RC; Hannun YA
Structure; 2015 Aug; 23(8):1482-1491. PubMed ID: 26190575
[TBL] [Abstract][Full Text] [Related]
17. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
18. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
19. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.
Blachnio-Zabielska A; Baranowski M; Zabielski P; Gorski J
J Cell Physiol; 2010 Nov; 225(3):786-91. PubMed ID: 20568228
[TBL] [Abstract][Full Text] [Related]
20. Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death.
Sundaram K; Mather AR; Marimuthu S; Shah PP; Snider AJ; Obeid LM; Hannun YA; Beverly LJ; Siskind LJ
Biochem J; 2016 Mar; 473(6):743-55. PubMed ID: 26747710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
